Med ePad has developed a 7-inch interactive touch-screen mobile internet device intended for healthcare service providers to loan to patients. The tablets are designed to empower patients to manage self-care and address issues such as missed appointments, post-operative care and long-term condition management. The company says the system aims to deliver financial savings and enhance quality of patient care. Leadership includes founder Rob Connell, new chairman Tom Nawojczyk and new chief executive officer John Hopkins. Med ePad has been backed by regional funds and plans to use current financing to carry out ongoing trials with NHS customers. The company intends to progress those trials through to full-scale commercial implementation later in 2013. Med ePad develops interactive 7-inch tablet devices and companion apps created in conjunction with NHS healthcare professionals to enable patients to manage self-care and address missed appointments, post-operative care and long-term condition management. The company is led by chief technical officer and founder Rob Connell and is based at Liverpool Science Park in the UK. Its products combine hardware and software aimed at improving patient engagement and supporting clinical workflows. Med ePad plans to use the new funding tranche to hire additional staff and expand its project development pipeline. The article reports a follow-on investment that increases a key investor’s commitment, indicating ongoing external support for the business and its growth plans. Med ePad has developed a 7-inch interactive touch-screen tablet designed for healthcare service providers, preloaded with condition-specific apps created with NHS healthcare professionals. The device enables recording of medication regimes and daily living patterns, sending appointment reminders, conducting online consultations, and accessing condition-specific information in patients' preferred languages. The company says the product aims to improve treatment efficiency and empower patients to better manage self-care. Med ePad intends to use the latest funding to develop initial apps and run real trials with healthcare services in both primary and secondary care. The company was founded by CTO Rob Connell and is based at Liverpool Science Park. Its current fundraising news reports a £50k investment from the North West Fund for Biomedical.

Total raised

$1M

Funding rounds

3

Latest round

Equity

Latest activity

Jan 2013